Concepedia
Statistics
Publications
14
Citations
924
H-Index
12
Active since
1963
Affiliations
Icahn School of Medicine at Mount Sinai(Current)
Cornell University
Mount Sinai Hospital
Mount Sinai Medical Center
NewYork–Presbyterian Hospital
Deborah Lehrer is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, oncology, and pharmacology.
Publications per year
1963–2018
Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
Abby B. Siegel, E. Cohen, Allyson J. Ocean et al. · Journal of Clinical Oncology · 2008 · 510 citations · Full text
Medicine, Oncology, Pharmacology +17
Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
Chrisann Kyi, Vladimir Roudko, Rachel Lubong Sabado et al. · Clinical Cancer Research · 2018 · 138 citations · Full text
Medicine, Immunology, Oncology +10
Bevacizumab in unresectable hepatocellular carcinoma (HCC) for patients without metastasis and without invasion of the portal vein
Jonathan D. Schwartz, M. Schwartz, Deborah Lehrer et al. · Journal of Clinical Oncology · 2006 · 56 citations
Medicine, Oncology, Pharmacotherapy +11
Thalidomide in Advanced Hepatocellular Carcinoma with Optional Low-Dose Interferon-α2a upon Progression
Jonathan D. Schwartz, Max W. Sung, Myron Schwartz et al. · The Oncologist · 2005 · 35 citations · Full text
Bevacizumab in hepatocellular carcinoma (HCC) in patients without metastasis and without invasion of the portal vein
Jonathan D. Schwartz, M. Schwartz, Deborah Lehrer et al. · Journal of Clinical Oncology · 2005 · 27 citations
Medicine, Oncology, Pharmacology +14
1–5 of 14